Absence of germline CHK2 mutations in familial gastric cancer

Japanese Journal of Cancer Research

Volumn 91, Issue 9, 2000, Pages 875-879

  Kimura, Kenji ^a,b   Shinmura, Kazuya ^a   Yoshimura, Kimio ^a   Shimizu, Kimihiro ^a   Katai, Hitoshi ^b   Beppu, Yasuo ^b   Moriya, Hideshige ^c   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

CHK2; Familial gastric cancer; Germline mutation

Indexed keywords

OLIGONUCLEOTIDE; PRIMER DNA; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; INTRON; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIBLING; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

AGED; BASE SEQUENCE; FEMALE; GERM-LINE MUTATION; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN KINASES; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0033770263     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb01028.x     Document Type: Article

References (32)

1. Family history and the risk of stomach and colorectal cancer
2. New phenotypic aspects in a family with Lynch syndrome II
3. Association between family history and gastric carcinoma among young adults
4. BRCA1 mutations in primary breast and ovarian carcinomas
5. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer
6. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review
7. Familial gastric cancer: Overview and guidelines for management
8. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer
9. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome
10. E-Cadherin germline mutations in familial gastric cancer
11. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
12. Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer
13. Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history
14. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds
15. Methylation of the hMLH1 promoter in familial gastric cancer with microsatellite instability
16. RER phenotype and its associated mutations in familial gastric cancer
17. Familial gastric cancer: Clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations
18. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation
19. Prevalence and spectrum of germline mutations of p53 gene among patients with sarcoma
20. Germ-line p53 mutation is uncommon in patients with triple primary cancers
21. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma
22. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome
23. Li-Fraumeni syndrome - A molecular and clinical review
24. Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome
25. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
26. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
27. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
28. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
29. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
30. Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation
31. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53
32. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway